Searching News Database: fluocinolone acetonide
HSMN NewsFeed - 24 Apr 2012
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema
HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
HSMN NewsFeed - 2 Feb 2009
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
HSMN NewsFeed - 24 Mar 2008
DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
HSMN NewsFeed - 18 Mar 2008
Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
HSMN NewsFeed - 4 Apr 2007
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
pSivida Signs $165 Million(US) Collaborative Research and Licensing Agreement with Pfizer
HSMN NewsFeed - 26 Dec 2006
pSivida Enters Licensing Negotiations with Major Global Pharma for Drug Delivery Technologies
pSivida Enters Licensing Negotiations with Major Global Pharma for Drug Delivery Technologies
HSMN NewsFeed - 27 Nov 2006
Alimera Sciences Completes Second Tranche of Series B Financing, Receives $15.9 Million
Alimera Sciences Completes Second Tranche of Series B Financing, Receives $15.9 Million
HSMN NewsFeed - 8 May 2006
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Medicis Announces FDA Approval of SOLODYN -- minocycline HCl, USP -- Extended Release Tablets
Additional items found! 19
Members Archive contains
19 additional stories matching:
fluocinolone acetonide
(Password required)
fluocinolone acetonide
(Password required)
